PEREGRINE PHARMACEUTICALS, INC. COMMON STOCK PURCHASE AGREEMENT 9,285,714 SHARES OF COMMON STOCK June 16, 2006Common Stock Purchase Agreement • June 19th, 2006 • Peregrine Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • California
Contract Type FiledJune 19th, 2006 Company Industry JurisdictionThis Common Stock Purchase Agreement (this “Agreement”) is made and entered into as of June 16, 2006 (the “Effective Date”), by and between Peregrine Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Double U Master Fund LP (the “Investor”).